Pharmacovigilance at the National Orthopaedic Hospital Igbobi Lagos Nigeria: Knowledge and Attitudeof the Healthcare Workers Pharmacovigilance à l'hôpital orthopédique national d'Igbobi, Lagos, Nigéria : connaissances et attitudesdes professionnels de santé

Main Article Content

Funmi R. Fagboyo
Muinat. O. Abubakar
Mansurah B. Adio
Olumide I. Soyemi
Fisayo. A. Raji
Marianne. O. Melifonwu
Michael Agboola

Abstract

Background: Pharmacovigilance encompasses drug safety monitoring and adverse drug reactions (ADR) reporting. There is currently no literature on the knowledge of ADR monitoring and reporting amongst professional healthcare workers of the National Orthopaedic Hospital, Igbobi, Lagos.


Objectives: To determine healthcare workers' knowledge and attitude towards pharmacovigilance at the National Orthopaedic Hospital, Igbobi, Lagos.


Methods: A cross-sectional study was conducted at the centre. A questionnaire with focus on the knowledge and  attitudes of healthcare workers towards pharmacovigilance was administered to Pharmacists, Physicians, Nurses, Physiotherapists, Medical Laboratory Scientists and Radiographers; and retrieved accordingly after the healthcare workers had completed the filling of the questionnaire.


Results: The result indicated a satisfactory knowledge of drug safety monitoring and adverse drug reactions as  shown by a mean score of 36.24 + 5.25 in 74.7 % of respondents. The attitude towards adverse drug reaction reporting was also satisfactory with a mean score of 22.29 3.83 in 88.8 % of respondents. However, uncertainty about drug reaction and drug relationship (3.79 + 0.61 in 71 + 6 % of respondents) is the main barrier towards ADR reporting. Fear of legal consequences (3.28 + 0.58 in 88.8 % of respondents) was the least of the barriers. Lack of time (3.56 + 0.59 in 65.9 % of respondents), lack of adequate knowledge (3.59 + 0.60 in 65.8 % of respondents), lack of access to reporting tools (3.58 + 0.59 in 64.0 % of respondents), were also recognized as factors that may act as barriers towards effective adverse drug reaction reporting.


Conclusion: Health care workers in NOHIL have a satisfactory knowledge of pharmacovigilance. Their knowledge of pharmacovigilance has an important influence on their attitude towards ADR reporting.


 


Résumé

Contexte : La pharmacovigilance englobe la surveillance de la sécurité des médicaments et la notification des effets indésirables des médicaments (EIM). À l'heure actuelle, aucune donnée n'est disponible concernant les connaissances des professionnels de santé de l'Hôpital orthopédique national d'Igbobi, à Lagos, en matière de surveillance et de notification des effets indésirables.


Objectifs : Déterminer les connaissances et l'attitude des professionnels de santé en matière de  pharmacovigilance à l'hôpital orthopédique national d'Igbobi, à Lagos.


Méthodes : Une étude transversale a été menée au sein de l'établissement. Un questionnaire portant sur les  connaissances et les attitudes des professionnels de santé en matière de pharmacovigilance a été administré aux pharmaciens, médecins, infirmiers, physiothérapeutes, techniciens de laboratoire et manipulateurs en radiologie ; les questionnaires ont été récupérés une fois remplis par les participants.


Résultats : Les résultats indiquent une connaissance satisfaisante de la pharmacovigilance et des effets  indésirables des médicaments, comme en témoigne un score moyen de 36,24 ± 5,25 obtenu par 74,7 % des répondants. L'attitude à l'égard de la notification des effets indésirables des médicaments était également satisfaisante, avec un score moyen de 22,29 ± 3,83 obtenu par 88,8 % des répondants. Cependant, l'incertitude quant aux réactions médicamenteuses et aux interactions médicamenteuses (3,79 ± 0,61 chez 71,6 % des répondants) constitue le principal frein à la notification des effets indésirables. La crainte de conséquences juridiques (3,28 ± 0,58 chez 88,8 % des répondants) représente le moindre frein. Le manque de temps (3,56 ± 0,59 chez 65,9 % des répondants), le manque de connaissances adéquates (3,59 ± 0,60 chez 65,8 % des répondants), le manque d'accès aux outils de signalement (3,58 ± 0,59 chez 64,0 % des répondants) ont également été reconnus comme des facteurs pouvant constituer des obstacles à une notification efficace des effets indésirables des médicaments.


Conclusion : Les professionnels de santé du NOHIL possèdent des connaissances satisfaisantes en matière de  pharmacovigilance. Ces connaissances influencent fortement leur attitude face à la notification des effets indésirables des médicaments.

Views: 0Downloads: 0

Downloads

Download data is not yet available.

Article Details

Section

PUBLIC HEALTH PHARMACY

How to Cite

Fagboyo, F., Abubakar, M., Adio, M., Soyemi, O., Raji, F., Melifonwu, M., & Agboola, M. (2026). Pharmacovigilance at the National Orthopaedic Hospital Igbobi Lagos Nigeria: Knowledge and Attitudeof the Healthcare Workers: Pharmacovigilance à l’hôpital orthopédique national d’Igbobi, Lagos, Nigéria : connaissances et attitudesdes professionnels de santé. West African Journal of Pharmacy, 37(2), 183-190. https://doi.org/10.82351/wajp.vol37no2.498

Share

References

1.Hamid A, Rahim R, Teo SP (2022). Pharmacovigilance and Its Importance for Primary Health Care Professionals. Korean Journal of Family Medicine 43(5): 290. https://doi.org/10.4082/kjfm.21.0193.

2.Lucas S, Ailani J, Smith TR, Abdrabboh A, Xue F, Navetta MS (2022). Pharmacovigilance: reporting requirements throughout a product's lifecycle. Therapeutic Advances in Drug Safety 13:1-16.

3.Güner MD, Ekmekci PE (2019). Healthcare professionals' pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates. Journal of Drug Assessment 8(1): 13-20.

4.García-Abeijon P, Costa C, Taracido M, Herdeiro MT, Torre C, Figueiras A. (2023). Factors Associated with Underreporting of Adverse Drug Reactions by Health Care Professionals: A Systematic Review Update..Drug Safety 46(7): 625-636.

5.Hamid M, Osman M (2025). Knowledge, attitude, and practice of pharmacovigilance among healthcare professionals at a tertiary level hospital, Sudan: a cross sectional study. BMC Health Services Research 26(1):89.

6.Saleem AH, Al-Qazaz HKh, Allela OQ (2025). Assessment of knowledge, attitudes, and practices of healthcare providers on pharmacovigilance: a cross- ectional survey in general hospitals in Iraq. Pharmacia 72: 1-8.

7.Gordhon Y, Padayachee N (2020). Evaluating the knowledge, attitude and practices of healthcare workers towards adverse drug reaction reporting at a public tertiary health institution in Johanessburg, South Africa. International Journal of Africa Nursing Sciences 12: 1-28.

8.Rotimi K, Fagbemi B, Omole G, Biambo Aa, Ibinaiye T, Iwegbu A, Ogunmola O, Oguoma C, Oresanya O (2024). Awareness, knowledge, attitude, and practice of adverse drug reaction reporting among health workers in primary health centres participating in seasonal malaria chemoprevention campaign in Nigeria in 2022: a cross-sectional survey. BMC Health Services Research 24:952 p1-11.

9.Fadare JO, Enwere OO, Afolabi AO, Chedi BAZ and Musa A (2011). Knowledge, Attitude and Practice of Adverse Drug Reaction Reporting among Healthcare Workers in a Tertiary Centre in Northern Nigeria. Tropical Journal of Pharmaceutical Research 10 (3): 235-242.

10. Alwidyan T, Banat A, Odeh M, Ibrahim HA, Harahsheh E (2025). Knowledge, attitude, and practice among community pharmacists toward adverse drug reaction reporting and pharmacovigilance: A nationwide survey. Exploratory Research in Clinical and Social Pharmacy 18: 100578.

11. Valinciute A. Gerbutaviciene RJ, Paukstaitiene R, Kubiliene L(2023). Pharmacovigilance and Adverse Drug Reaction Reporting among the General Public in Lithuania: A Cross-Sectional Study. Healthcare 11:1133.

12. Sharif MA, Kazi AA, Rweyemamu MA (2021). Why Pharmacovigilance and Adverse Drug Reaction Reporting Practices Lacks in Developing Countries: A Study from Pakistan. Systematic Reviews in Pharmacy 12(11): 604-610.

13. Burud I, Daher MA, Din HB, Agarwal P, Zakaria J, Agarwal R (2021). Knowledge, attitudes, and practices related to adverse drug reaction reporting by healthcare professionals in a tertiary hospital in Malaysia. Journal of Applied Pharmaceutical Science 11(10):79-87.

14. Kunene KN, Teo SP (2022). Systematic Review - Knowledge, Attitudes and Practices of Healthcare Workers in Reporting Adverse Drug Reactions in Sub Saharan Africa for Pharmacovigilance. Nepal Journal of Medical Sciences 7(2):38-45.

15. Osoro IN, Suhaib KP, Jamuna RR and Rajanandh MG (2025). Barriers to and facilitators of healthcare professionals in ADR reporting in a tertiary care hospital in India. BMC Health Services Research 25:166.

16. Cheema E, Haseeb A, Khan TM, Sutcliffe P, Singer DR (2017). Barriers to reporting of adverse drugs reactions: a cross sectional study among community pharmacists in United Kingdom. Pharmacy Practice 15(3):931.

Similar Articles

You may also start an advanced similarity search for this article.